Global Precision Medicine Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

An emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person

The Global Precision Medicine Market is estimated to be USD 30.07 Bn in 2023 and is expected to reach USD 52.11 Bn by 2028 growing at a CAGR of 11.62%.

Market dynamics, which refers to the ever-changing and evolving conditions, trends, and forces that impact the industries, is crucial for industry overview. It includes consumer demands, competition, technological advancements, economic shifts, and regulatory changes. We monitor the market and analyze the balance between demand and supply. Market dynamics that include drivers, restraints, opportunities, challenges, and insights are needed to make strategic decisions, whether entering new markets, launching new products, or setting pricing strategies.

The emerging trends in the market require market analysis to help set goals, make informed decisions about market entry and product development pricing, and inspire innovation to stay competitive and meet changing requirements. One of the most important elements is to analyze competitors to identify the gaps specific to the geographic location, product offerings, pricing, and opportunity areas for growth in internal and external development.

Understanding consumer behavior and market trends holistically is necessary to expand the company into new horizons and position itself in a new or existing market. It helps gain a competitive edge, save time & money, and reduce risks in the long term.

Market Segmentations

• The Global Precision Medicine Market is segmented based on Inhibitor Type, Indication, End-Users, and Geography.
• The global precision medicine market, categorized by inhibitor types such as Inhibitor Drugs, Monoclonal Antibodies, and Cell & Gene Therapy, reflects a diverse landscape addressing different aspects of personalized treatment. Inhibitor drugs and monoclonal antibodies target specific molecules, providing targeted therapy with minimized side effects. On the other hand, cell and gene therapy represents a groundbreaking approach with the potential for curative treatments by modifying a patient's cells.
• As the precision medicine field continues to evolve, ongoing research and technological advancements are expected to drive innovations in all three inhibitor types. Future trends may include deeper genomics and molecular profiling integration, developing combination therapies, and increased accessibility to cell and gene therapies. Industry players are likely to focus on collaboration, regulatory considerations, and addressing manufacturing challenges to unlock the full potential of precision medicine across various therapeutic areas.

Recent Development

• Roche received EC approval to expand the Hemlibra (emicizumab) European Union (EU) marketing authorization. -Feb 2023
• AstraZeneca (UK) collaborated with Scorpion. - Jan 2022

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some companies covered in this report are 23andMe, Abbott Laboratories, Agilent Technologies, etc.

Countries Studied

• America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
• Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Ireland, Luxembourg, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
• Middle East and Africa (Egypt, Israel, Qatar, Nigeria, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
• Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

• The report presents a detailed Ansoff matrix analysis for the Global Precision Medicine Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
• The publisher analyses the Global Precision Medicine Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
• Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Precision Medicine Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 and the impact of economic slowdown & impending recession on the market are also featured in the report.
• The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights

• A complete analysis of the market, including parent industry
• Important market dynamics and trends
• Market segmentation
• Historical, current, and projected size of the market based on value and volume
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market